Coccidioidomycosis Skin Testing in a Commercially Insured Population, United States, 2014-2017

Citation metadata

Date: Mar. 2020
From: Emerging Infectious Diseases(Vol. 26, Issue 3)
Publisher: U.S. National Center for Infectious Diseases
Document Type: Report
Length: 1,080 words
Lexile Measure: 1290L

Document controls

Main content

Abstract :

Coccidioidomycosis skin testing appears to be uncommon, based on US health insurance claims data. Patient demographic features were consistent with the approval of the test for adults, but few patients had previous coccidioidomycosis diagnosis codes supporting its use for detecting delayed-type hypersensitivity in those with a history of pulmonary coccidioidomycosis.

Source Citation

Source Citation   

Gale Document Number: GALE|A617620978